false
0001397183
0001397183
2026-09-04
2026-09-04
0001397183
IVDA:CommonStockParValue0.00001Member
2026-09-04
2026-09-04
0001397183
IVDA:CommonStockPurchaseWarrantsMember
2026-09-04
2026-09-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
September
4, 2026
Date
of Report (Date of earliest event reported)
IVEDA
SOLUTIONS, INC.
(Exact
Name of Registrant as Specified in its Charter)
| Delaware |
|
001-41345 |
|
20-2222203 |
| (State
or other jurisdiction |
|
(Commission |
|
(I.R.S.
Employer |
| of
incorporation) |
|
File
Number) |
|
Identification
No.) |
1744
S. Val Vista, Suite 213
Mesa,
Arizona |
|
85204 |
| (Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (480) 307-8700
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.00001 |
|
IVDA |
|
The
Nasdaq Stock Market LLC |
| Common
Stock Purchase Warrants |
|
IVDAW |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As
previously reported, on March 6, 2026, Iveda Solutions, Inc. (the “Company”) received a notification letter (the “Closing
Bid Price Deficiency Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying
the Company that, based on the previous 30 consecutive business days, the closing bid price for the Company’s common stock has
been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2)
(“Rule 5550(a)(2)”). The Company had 180 days, or until September 2, 2026, to regain compliance with Rule 5550(a)(2) by maintaining
a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. Additionally, Nasdaq notified the Company
that it might be eligible for an additional compliance period of 180 calendar days if, on September 2, 2026, the Company met the continued
listing requirement for market value of publicly held shares and all other applicable standards for initial listing on the Nasdaq Capital
Market (with the exception of the closing bid price requirement) based on the Company’s then most recent public filings and market
information, and the Company provided written notice to Nasdaq of its intent to cure during such additional compliance period of 180
calendar days the deficiency in the Company’s compliance with the minimum closing bid price requirement of Rule 5550(a)(2), including,
without limitation, by effecting a reverse stock split, if necessary.
On
September 2, 2026, the Company submitted a request to Nasdaq for an additional 180 calendar day period to regain compliance with the
minimum bid price requirement and gave notice of its intention to cure the deficiency during the second compliance period by effecting
a reverse split, if necessary.
On
September 4, 2026, the Company received a letter (the “Second Bid Price Grace Period Letter”) from Nasdaq advising that the
Company has been granted an additional 180 calendar day period, or until March 1, 2027, to regain compliance with the minimum bid price
requirement. The determination was based on the Company meeting the continued listing requirement for market value of publicly held shares
and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the bid price requirement.
The second 180 day period relates exclusively to the bid price deficiency, and the Company may be delisted during the 180 days for failure
to maintain compliance with any other listing requirements which occurs during this period.
The
Company intends to monitor closely the closing bid price of its common stock, and the other listing requirements, and to consider plans
for regaining compliance with Rule 5550(a)(2). The Company may, if appropriate, consider implementing a reverse stock split of its outstanding
common stock to regain compliance with the minimum bid price requirement. While the Company plans to review all available options, there
can be no assurance that it will be able to regain compliance with the bid price requirement or maintain compliance with the other applicable
listing requirements during the additional 180 calendar day compliance period ending on March 1, 2027. If compliance cannot be demonstrated
by March 1, 2027, Nasdaq will provide written notification that the Company’s securities will be delisted. At that time, the Company
may appeal Nasdaq’s determination to a Hearings Panel and be asked to provide a plan to regain compliance. There can be no assurance
that the Company would appeal Nasdaq’s delisting determination or that such an appeal would be successful.
The
Company, by filing this Form 8-K, discloses its receipt of the Letter in accordance with Nasdaq Listing Rule 5810(b).
Item 9.01 Financial Statements and Exhibits
(a) Exhibits
| Number |
|
Description |
| 99.1 |
|
Press Release dated September 9, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Dated:
September 9, 2026 |
|
|
| |
|
|
| |
IVEDA
SOLUTIONS, INC. |
| |
|
|
| |
By: |
/s/
David Ly |
| |
Name: |
David
Ly |
| |
Title: |
Chief
Executive Officer |
Exhibit
99.1
NASDAQ
Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance
Extension
provides additional time through March 1, 2027, as Iveda advances commercial execution across its AI and connected-technology portfolio
MESA,
Ariz. – September 9, 2026 – Iveda® (NASDAQ: IVDA),a global provider of AI-powered video intelligence, smart infrastructure
and connected technologies, today announced that The Nasdaq Stock Market has granted Iveda an additional 180-calendar-day period, through
March 1, 2027, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement under Listing Rule 5550(a)(2).
Nasdaq
granted the additional compliance period after determining that Iveda satisfied the continued-listing requirement for the market value
of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, except the minimum bid
price requirement. The notice has no immediate effect on the listing or trading of Iveda’s common stock, which continues to trade
on the Nasdaq Capital Market under the symbol “IVDA.”
“Nasdaq’s
decision gives us additional time to address the bid-price requirement in a deliberate and responsible way, while our team remains focused
on execution,” said David Ly, founder and CEO of Iveda. “Across the business, we are seeing serious engagement around our
AI video intelligence, autonomous aerial systems, smart infrastructure and connected-care technologies. Our job now is to turn that engagement
into pilots, partnerships, deployments and long-term value. This extension gives us time to keep doing that work while we evaluate the
best path to compliance for Iveda and our shareholders.”
COMPLIANCE
PATH
To
regain compliance, Iveda’s common stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive
business days during the additional compliance period, although Nasdaq may require a longer period. Iveda intends to monitor its closing
bid price and continued compliance with Nasdaq’s other listing standards and will evaluate all available options to regain compliance,
which may include a reverse stock split if determined to be appropriate and necessary.
The
Company has not announced a decision to implement a reverse stock split. Any such action would be evaluated based on the circumstances
at the time and communicated through appropriate public disclosures. There can be no assurance that Iveda will regain compliance with
the minimum bid price requirement or maintain compliance with other applicable listing requirements during the additional period.
EXECUTING
ACROSS A BROADER OPPORTUNITY PIPELINE
The
additional compliance period comes as Iveda continues advancing a broader commercial strategy built around IvedaAI™, CEREBRO™
and a growing portfolio of intelligent devices and autonomous systems. The Company is actively supporting customer evaluations, technical
demonstrations and partner-led opportunities across public safety, critical infrastructure, transportation, healthcare, retail and government
markets in the United States and internationally.
Recent
activity includes the launch and market introduction of IvedaAir™, Iveda’s line of AI-powered rotary-wing unmanned aircraft
systems designed for extended-endurance and mission-critical operations. Iveda is working with prospective customers, government stakeholders
and strategic organizations to define operating requirements, platform configurations and potential pathways toward demonstrations, evaluations,
pilots and procurement opportunities.
At
the same time, Iveda continues working through established channel and technology relationships to expand the reach of its AI video intelligence
and connected-technology solutions across Europe, Asia, the Middle East and the Americas. These initiatives remain subject to customer
evaluation, contracting, funding, regulatory requirements and other customary conditions, and there can be no assurance that any particular
opportunity will result in revenue.
“We
understand that shareholders want progress they can see and results that matter,” Ly continued. “We are not treating this
extension as a pause. We are treating it as time to execute - to support our partners, advance customer opportunities and build the foundation
for meaningful, sustainable growth. Our Nasdaq listing remains important to Iveda, and we intend to use this period responsibly.”
ADDITIONAL
INFORMATION
The
Company’s related Current Report on Form 8-K is available through the SEC’s EDGAR database and Company website.
ABOUT
IVEDA SOLUTIONS®
Since
2003, Iveda® (NASDAQ: IVDA) has transformed everyday infrastructure into intelligent technology designed to make the world safer,
smarter and more connected. Today, Iveda is building its connected-technology ecosystem around CEREBRO™, bringing together a growing
portfolio of intelligent devices and systems spanning video intelligence, IoT, autonomous systems, real-time location, energy management
and care.
At
the forefront of this ecosystem is IvedaAI™, Iveda’s flagship AI video intelligence platform, transforming cameras into intelligent
tools that can understand real-world environments, surface meaningful insights and help organizations respond faster - so they can Focus
on What Matters.
With
operations across the United States, Taiwan, the Philippines, Egypt and Spain, Iveda’s global team is united by one vision: to
simplify everyday life, one innovation at a time.
FORWARD-LOOKING
STATEMENTS
This
press release contains forward-looking statements, including statements regarding the Company’s ability to regain compliance with
Nasdaq’s minimum bid price requirement; its evaluation of available compliance options, including a potential reverse stock split;
its commercial strategy and growth objectives; the development, capabilities and market adoption of its products; anticipated demonstrations;
customer and partner engagement; and prospective evaluations, pilots, partnerships, procurement opportunities and deployments.
Forward-looking
statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results
to differ materially from those expressed or implied. These risks include the Company’s ability to regain and maintain compliance
with Nasdaq listing standards; convert prospective opportunities into binding contracts, deployments and revenue; meet customer, technical,
regulatory and funding requirements; and the other risks described in Iveda’s filings with the Securities and Exchange Commission.
There can be no assurance that compliance will be achieved within the additional period or that prospective business opportunities will
result in completed transactions or revenue. The Company undertakes no obligation to update any forward-looking statement except as required
by applicable law.
+++++
Media
Contact
Olivia
Civiletto Erwin
olivia@dottedlinecomm.com
716.785.1108
